0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Status and Forecast 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-18V1462
Home | Market Reports | Health | Reproductive Health
Global Hypoactive Sexual Desire Disorder HSDD Treatment Market Size Status and Forecast 2021 2027

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-18V1462
Report
July 2021
100 Pages
QYResearch
Region: Global, North America, Europe, Japan, Southeast Asia, Central & South America,
Description
Table of Content
Tables & Figures
Hypoactive sexual desire disorder (HSDD) is the absence of sexual thoughts and fantasies causing low libido and sex drive in women population worldwide.
Market Analysis and Insights: Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
The global Hypoactive Sexual Desire Disorder (HSDD) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market.
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Scope and Market Size
Hypoactive Sexual Desire Disorder (HSDD) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Buspirone
Bupropion
Testosterone
Flibanserin
Bremelanotide
Cognitive Behavior Therapy

Segment by Application

Hospitals
Clinic
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

AMAG Pharmaceuticals
Allergan, Plc.
Ivix LLX
EndoCeutics, Inc.
Emotional Brain BV
S1 Biopharma, Inc.
Sprout Pharmaceuticals, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Buspirone
1.2.3 Bupropion
1.2.4 Testosterone
1.2.5 Flibanserin
1.2.6 Bremelanotide
1.2.7 Cognitive Behavior Therapy
1.3 Market by Application
1.3.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2016-2027)
2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Regions
2.2.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Dynamic
2.3.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
2.3.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
2.3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
2.3.4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue
3.1.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue (2016-2021)
3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue
3.4 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio
3.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2020
3.5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players Head office and Area Served
3.6 Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
3.7 Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Type
4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2022-2027)
5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Application
5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
6.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
6.2.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
6.2.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
6.2.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
6.3.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
6.3.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
6.3.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
6.4.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
6.4.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
7.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
7.2.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
7.3.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
7.4.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
8.2.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
8.3.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region
8.4.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
9.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
9.2.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
9.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
9.3.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
9.4 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
9.4.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
10.2.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
10.3.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
10.4.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Company Details
11.1.2 AMAG Pharmaceuticals Business Overview
11.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.1.5 AMAG Pharmaceuticals Recent Development
11.2 Allergan, Plc.
11.2.1 Allergan, Plc. Company Details
11.2.2 Allergan, Plc. Business Overview
11.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.2.5 Allergan, Plc. Recent Development
11.3 Ivix LLX
11.3.1 Ivix LLX Company Details
11.3.2 Ivix LLX Business Overview
11.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.3.5 Ivix LLX Recent Development
11.4 EndoCeutics, Inc.
11.4.1 EndoCeutics, Inc. Company Details
11.4.2 EndoCeutics, Inc. Business Overview
11.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.4.5 EndoCeutics, Inc. Recent Development
11.5 Emotional Brain BV
11.5.1 Emotional Brain BV Company Details
11.5.2 Emotional Brain BV Business Overview
11.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.5.5 Emotional Brain BV Recent Development
11.6 S1 Biopharma, Inc.
11.6.1 S1 Biopharma, Inc. Company Details
11.6.2 S1 Biopharma, Inc. Business Overview
11.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.6.5 S1 Biopharma, Inc. Recent Development
11.7 Sprout Pharmaceuticals, Inc.
11.7.1 Sprout Pharmaceuticals, Inc. Company Details
11.7.2 Sprout Pharmaceuticals, Inc. Business Overview
11.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.7.5 Sprout Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Buspirone
    Table 3. Key Players of Bupropion
    Table 4. Key Players of Testosterone
    Table 5. Key Players of Flibanserin
    Table 6. Key Players of Bremelanotide
    Table 7. Key Players of Cognitive Behavior Therapy
    Table 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2016-2021)
    Table 12. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2022-2027)
    Table 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
    Table 15. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
    Table 16. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
    Table 17. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
    Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players (2016-2021)
    Table 20. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2020)
    Table 21. Ranking of Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
    Table 25. Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2016-2021)
    Table 29. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2016-2021)
    Table 33. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 40. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 41. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 46. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 52. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 53. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 58. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 64. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 65. AMAG Pharmaceuticals Company Details
    Table 66. AMAG Pharmaceuticals Business Overview
    Table 67. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 68. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 69. AMAG Pharmaceuticals Recent Development
    Table 70. Allergan, Plc. Company Details
    Table 71. Allergan, Plc. Business Overview
    Table 72. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 73. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 74. Allergan, Plc. Recent Development
    Table 75. Ivix LLX Company Details
    Table 76. Ivix LLX Business Overview
    Table 77. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 78. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 79. Ivix LLX Recent Development
    Table 80. EndoCeutics, Inc. Company Details
    Table 81. EndoCeutics, Inc. Business Overview
    Table 82. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 83. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 84. EndoCeutics, Inc. Recent Development
    Table 85. Emotional Brain BV Company Details
    Table 86. Emotional Brain BV Business Overview
    Table 87. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 88. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 89. Emotional Brain BV Recent Development
    Table 90. S1 Biopharma, Inc. Company Details
    Table 91. S1 Biopharma, Inc. Business Overview
    Table 92. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 93. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 94. S1 Biopharma, Inc. Recent Development
    Table 95. Sprout Pharmaceuticals, Inc. Company Details
    Table 96. Sprout Pharmaceuticals, Inc. Business Overview
    Table 97. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 98. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 99. Sprout Pharmaceuticals, Inc. Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Buspirone Features
    Figure 3. Bupropion Features
    Figure 4. Testosterone Features
    Figure 5. Flibanserin Features
    Figure 6. Bremelanotide Features
    Figure 7. Cognitive Behavior Therapy Features
    Figure 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2020 VS 2027
    Figure 9. Hospitals Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Others Case Studies
    Figure 12. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered
    Figure 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions: 2020 VS 2027
    Figure 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2022-2027)
    Figure 17. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2020
    Figure 18. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2020
    Figure 20. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2016-2021)
    Figure 21. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2022-2027)
    Figure 22. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 24. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 25. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
    Figure 26. United States Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 30. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 31. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
    Figure 32. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2016-2027)
    Figure 42. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 50. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 51. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
    Figure 52. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
    Figure 58. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 62. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 63. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 64. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 65. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 66. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 67. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and United States Prenatal Education Instrument Market Insights Forecast to 2027
Global and United States Prenatal Education Instrument Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7D3408
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and China Maternity Color Ultrasound Diagnostic Equipment Market Insights Forecast to 2027
Global and China Maternity Color Ultrasound Diagnostic Equipment Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10R3375
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and China Pregnant Women Underwear Market Insights Forecast to 2027
Global and China Pregnant Women Underwear Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10E3374
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and United States Cervical Biopsy Forceps Market Insights Forecast to 2027
Global and United States Cervical Biopsy Forceps Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-31G6614
Tue Sep 21 00:00:00 UTC 2021

Add to Cart